Concerns over participant suicides prematurely abort a clinical trial of potentially significant impact on public health: how will we make progress in timid times?
- PMID: 21267679
- PMCID: PMC3069144
- DOI: 10.1007/s11920-011-0179-1
Concerns over participant suicides prematurely abort a clinical trial of potentially significant impact on public health: how will we make progress in timid times?
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X. Lancet. 2010. PMID: 20709233 Clinical Trial.
References
-
- Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142:532–546. - PubMed
-
- Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71:1259–1272. - PubMed
-
- Tarricone I, Atti AR, Salvatori F, et al. Weight gain in antipsychotic-naive patients: a review and meta-analysis. Psychol Med. 2010;40:187–200. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources